Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: a randomized controlled trial.
about
Modulation of cytokine release and gene expression by the immunosuppressive domain of gp41 of HIV-1Micronutrients in HIV/AIDS: is there evidence to change the WHO 2003 recommendations?Role of selenium in HIV infectionMicronutrient supplementation in children and adults with HIV infectionHow to use the world's scarce selenium resources efficiently to increase the selenium concentration in foodOxidative stress and age-related changes in T cells: is thalassemia a model of accelerated immune system aging?Dietary selenium in adjuvant therapy of viral and bacterial infectionsThe roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunctionFactors associated with serum retinol, alpha-tocopherol, carotenoids, and selenium in Hispanics with problems of HIV, chronic hepatitis C, and drug use.Effect of micronutrient supplementation on disease progression in asymptomatic, antiretroviral-naive, HIV-infected adults in Botswana: a randomized clinical trialNutrition issues in chronic drug users living with HIV infection.Gastric and intestinal barrier impairment in tropical enteropathy and HIV: limited impact of micronutrient supplementation during a randomised controlled trialEchinacea purpurea along with zinc, selenium and vitamin C to alleviate exacerbations of chronic obstructive pulmonary disease: results from a randomized controlled trial.Micronutrient supplementation in adults with HIV infection.Mindfulness-oriented recovery enhancement for chronic pain and prescription opioid misuse: results from an early-stage randomized controlled trial.Serum Micronutrient Status of Haart-Naïve, HIV Infected Children in South Western Nigeria: A Case Controlled Study.The transmembrane protein of the human endogenous retrovirus--K (HERV-K) modulates cytokine release and gene expressionMindfulness-oriented recovery enhancement ameliorates the impact of pain on self-reported psychological and physical function among opioid-using chronic pain patients.Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: a meta-analysis in the highly active antiretroviral therapy era.Pre-antiretroviral therapy serum selenium concentrations predict WHO stages 3, 4 or death but not virologic failure post-antiretroviral therapy.Effect of dietary selenium yeast supplementation on porcine circovirus type 2 (PCV2) infections in mice.Role of selenium-containing proteins in T-cell and macrophage function.Effect of selenium supplementation on CD4 T-cell recovery, viral suppression, morbidity and quality of life of HIV-infected patients in Rwanda: study protocol for a randomized controlled trial.Nutrition and disease progression pre-highly active antiretroviral therapy (HAART) and post-HAART: can good nutrition delay time to HAART and affect response to HAART?Effect of selenium supplementation on CD4+ T-cell recovery, viral suppression and morbidity of HIV-infected patients in Rwanda: a randomized controlled trialMicronutrients, N-acetyl cysteine, probiotics and prebiotics, a review of effectiveness in reducing HIV progression.Effect of probiotic bacteria on microbial host defense, growth, and immune function in human immunodeficiency virus type-1 infectionHigh rates of serum selenium deficiency among HIV- and HCV-infected and uninfected drug users in Buenos Aires, ArgentinaPlasma Micronutrient Concentrations Are Altered by Antiretroviral Therapy and Lipid-Based Nutrient Supplements in Lactating HIV-Infected Malawian Women.Impact of selenium supplementation on fish antiviral responses: a whole transcriptomic analysis in rainbow trout (Oncorhynchus mykiss) fed supranutritional levels of Sel-Plex®.HIV-1, reactive oxygen species, and vascular complicationsCorrelation of selenium and zinc levels to antiretroviral treatment outcomes in Thai HIV-infected children without severe HIV symptomsRecruitment, Follow-Up and Characteristics of HIV Infected Adults who Use Illicit Drugs in Southern Africa.HIV-1 Gag Blocks Selenite-Induced Stress Granule Assembly by Altering the mRNA Cap-Binding Complex.Selenoproteins mediate T cell immunity through an antioxidant mechanism.Randomized, double-blind, placebo-controlled trial of selenium supplements among HIV-infected pregnant women in Tanzania: effects on maternal and child outcomes.Thioredoxin reductase-1 negatively regulates HIV-1 transactivating protein Tat-dependent transcription in human macrophagesThe influence of selenium on immune responses.Food-chain selenium and human health: emphasis on intake.Dimethyl fumarate modulation of immune and antioxidant responses: application to HIV therapy.
P2860
Q21133706-B30B0E99-ECC1-419E-97E4-D6F3E36EB62BQ22241202-CA6FEC7B-A982-4AC9-BD17-08C41EC1C7C8Q22242299-A98B3B89-6564-4029-9DFC-CE36D9BA4C80Q24235504-AC1EC378-4188-4089-BF12-B73EA368E31BQ24642934-19AA4A6F-DB11-4856-B496-B5B38BE4E7ADQ26752041-39D2552C-B66F-4B2E-890F-F3F5E69777FDQ28082206-06FF4137-9E67-46C1-A3B5-776F9BA1E4AFQ28386344-86D39D2B-900C-4A40-BE81-B5BDC992239CQ30381373-EE6929D7-CBD5-475A-968B-C254FA15B330Q30624220-777B3059-989B-4708-8619-BBF93245A0F6Q33553170-67CA4471-E090-4268-AD82-AD1C8B84E989Q33626016-4496A7CE-C8BB-4A2F-B44D-58A9652083E3Q33742658-A894F576-3C87-4EBF-8DD7-67C0A6B027DAQ33761301-978F6058-E553-4F90-B122-7D38A0F61224Q33824759-2F770C02-45BA-49D6-AB31-1F38BFD4548EQ34087366-0472DB29-D1FC-4B9C-8370-176BE7BCC746Q34364497-BD60113B-DA2B-4C49-A80E-BE0277A272C7Q34403801-143FE0D7-C262-4D8F-93A9-62AE04B6DD7BQ34555483-45EEB55E-71DF-4A32-A503-E011A2402929Q34578091-47421498-746C-4830-9FF1-24A5E9282611Q35130407-06578E99-8991-43DA-8E71-1497EA1F5361Q35202342-F8463965-3E78-4F7E-8871-396DFBA8E3EDQ35240769-E6DFAFFB-BA13-45E3-ABF3-F42ABD0AB8C0Q35578701-29A13682-8EEB-42FB-9D7D-2F9063370895Q35648928-1287CFE8-B559-4AD3-9F37-09AAF3F2A60CQ35670966-A7DDB261-1ECE-4474-8C64-FAAF9A37B36CQ35678576-BEFD97F4-7CBB-4FBA-9409-CB314C7DEE76Q35759865-73D7ED6C-6447-49A8-BD4A-A3EF8FE50D65Q35894292-A7B17130-071C-4211-8F04-A3884400ED24Q35924600-D4DAFE2B-B533-4A76-B8F8-77CAABEB8A33Q36040759-519AEA71-0697-4412-B214-307A2423BA5DQ36139829-180211CD-871E-44CD-A74D-E0852049C2C3Q36539842-C232AE22-8EB3-4FB1-87E8-9C5A86AB79AEQ36755310-C1E57DE0-53BD-4058-B436-BAA75F11E477Q36761847-1B44016B-B122-42C8-BD17-56D8F5E03070Q36775790-06678E39-0B3C-44C4-97B6-A187ED44EC8FQ36980967-8D274FBC-37BF-4766-A214-CD17F08F489AQ37045286-8009A383-07C5-4B23-B61F-0381D2824409Q37112023-83FCC376-2816-46DA-AD92-A0ED43EE17E5Q37122279-CBAB2771-FBA4-43C7-94EB-EE8CB8603682
P2860
Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: a randomized controlled trial.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Suppression of human immunodef ...... a randomized controlled trial.
@ast
Suppression of human immunodef ...... a randomized controlled trial.
@en
Suppression of human immunodef ...... a randomized controlled trial.
@nl
type
label
Suppression of human immunodef ...... a randomized controlled trial.
@ast
Suppression of human immunodef ...... a randomized controlled trial.
@en
Suppression of human immunodef ...... a randomized controlled trial.
@nl
prefLabel
Suppression of human immunodef ...... a randomized controlled trial.
@ast
Suppression of human immunodef ...... a randomized controlled trial.
@en
Suppression of human immunodef ...... a randomized controlled trial.
@nl
P2093
P1476
Suppression of human immunodef ...... a randomized controlled trial.
@en
P2093
Alex Gonzalez
Barry E Hurwitz
Gail Shor-Posner
Jay S Skyler
Johanna R Klaus
Kevin J Maher
Maria M Llabre
Marianna K Baum
Neil Schneiderman
Peter J Lawrence
P304
P356
10.1001/ARCHINTE.167.2.148
P407
P577
2007-01-01T00:00:00Z